Chem. J. Chinese Universities ›› 2015, Vol. 36 ›› Issue (8): 1521.doi: 10.7503/cjcu20150194

• Organic Chemistry • Previous Articles     Next Articles

Synthesis and Antibacterial Activities of 3-S-(β-D-Glucosides)-1,2,4-triazole

ZHANG Ruibo, LU Junrui*(), LIU Jinbiao*(), MU Jiangbei, YANG Xuyun, WANG Hongyun, WANG Meijun, ZHANG He, ZHANG Mei   

  1. School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China
  • Received:2015-03-12 Online:2015-08-10 Published:2015-07-06
  • Contact: LU Junrui,LIU Jinbiao E-mail:lujunrui@tjut.edu.cn;liujinbiao007@126.com
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.21176194, 21476174)

Abstract:

Nine novel compounds of 5-substituted-phenyl-4-amino-3-S-(β-D-glucopyranosyl)-1,2,4-triazole(6a—6i) were synthesized from 5-substituted phenyl-4-amino-3-ylsulfanyl-4H-1,2,4-triazol by glycosylation and then by deacetylate in the system of sodium methylate, methanol and dichloromethane. Their structures were confirmed by 1H NMR, 13C NMR, IR and HRMS spectroscopy. The results of preliminary bioassay showed that most of the tested compounds display variable inhibitory activity against Escherichia coli, Staphylococcus aureus, Bacillus subtilis and Monilia albican. Especially, the compound 6g had the strongest antibacterial activity with minimum inhibitory concentration of 2, 8, 32, 8 μg/mL against the four tested strains respectively which are similar to or higher than those of the controlled drug fluconazole or triclosan. The interaction and binding free energy of compounds 6a—6i with FabⅠ were studied by Autodock.

Key words: 1,2,4-Triazole, S-β-D-Glucoside, Deacetylation, Antibacterial activity, FabⅠ

CLC Number: 

TrendMD: